|
1
|
Tuccari G and Barresi G: Lactoferrin in
human tumours: Immunohistochemical investigations during more than
25 years. Biometals. 24:775–84. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Deng M, Zhang W, Tang H, Ye Q, Liao Q,
Zhou Y, Wu M, Xiong W, Zheng Y, Guo X, et al: Lactotransferrin acts
as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT
through multiple mechanisms. Oncogene. 32:4273–4283. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou Y, Wang W, Zheng D, Peng S, Xiong W,
Ma J, Zeng Z, Wu M, Zhou M, Xiang J, et al: Risk of nasopharyngeal
carcinoma associated with polymorphic lactotransferrin haplotypes.
Med Oncol. 29:1452–1462. 2012. View Article : Google Scholar
|
|
4
|
Zhou Y, Zeng Z, Zhang W, Xiong W, Wu M,
Tan Y, Yi W, Xiao L, Li X, Huang C, et al: Lactotransferrin: A
candidate tumor suppressor-deficient expression in human
nasopharyngeal carcinoma and inhibition of NPC cell proliferation
by modulating the mitogen-activated protein kinase pathway. Int J
Cancer. 123:2065–2072. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou Y, Zeng Z, Zhang W, Xiong W, Li X,
Zhang B, Yi W, Xiao L, Wu M, Shen S, et al: Identification of
candidate molecular markers of nasopharyngeal carcinoma by
microarray analysis of subtracted cDNA libraries constructed by
suppression subtractive hybridization. Eur J Cancer Prev.
17:561–571. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ye Q, Zheng Y, Fan S, Qin Z, Li N, Tang A,
Ai F, Zhang X, Bian Y, Dang W, et al: Lactoferrin deficiency
promotes colitis-associated colorectal dysplasia in mice. PLoS One.
9:e1032982014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Teng CT and Gladwell W: Single nucleotide
polymorphisms (SNPs) in human lactoferrin gene. Biochem Cell Biol.
84:381–384. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Azevedo LF, Pecharki GD, Brancher JA,
Cordeiro CA Jr, Medeiros KG, Antunes AA, Arruda ES, Werneck RI, de
Azevedo LR, Mazur RF, et al: Analysis of the association between
lactotransferrin (LTF) gene polymorphism and dental caries. J Appl
Oral Sci. 18:166–170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bahar B, O'Halloran F, Callanan MJ,
McParland S, Giblin L and Sweeney T: Bovine lactoferrin (LTF) gene
promoter haplotypes have different basal transcriptional
activities. Anim Genet. 42:270–279. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Lima CF and Rodrigues LR:
Anticancer effects of lactoferrin: Underlying mechanisms and future
trends in cancer therapy. Nutr Rev. 72:763–773. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu MC and Yuan JM: Epidemiology of
nasopharyngeal carcinoma. Semin Cancer Biol. 12:421–429. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stella F, Weich N, Panero J, Fantl DB,
Schutz N, Fundia AF and Slavutsky I: Glutathione S-transferase P1
mRNA expression in plasma cell disorders and its correlation with
polymorphic variants and clinical outcome. Cancer Epidemiol.
37:671–674. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Velliyagounder K, Kaplan JB, Furgang D,
Legarda D, Diamond G, Parkin RE and Fine DH: One of two human
lactoferrin variants exhibits increased antibacterial and
transcriptional activation activities and is associated with
localized juvenile periodontitis. Infect Immun. 71:6141–6147. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moreno-Navarrete JM, Ortega FJ, Bassols J,
Castro A, Ricart W and Fernández-Real JM: Association of
circulating lactoferrin concentration and 2 nonsynonymous LTF gene
polymorphisms with dyslipidemia in men depends on glucose-tolerance
status. Clin Chem. 54:301–309. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao L, Zhou Y, Li X and Yi H: The
relationship of haplotype in lactotransferrin and its expression
levels in Chinese Han ovarian cancer. Acta Biochim Biophys Sin
(Shanghai). 43:884–890. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Heo S, Spoerk S, Birner-Gruenberger R and
Lubec G: Gel-based mass spectrometric analysis of hippocampal
transmembrane proteins using high resolution LTQ Orbitrap Velos
Pro. Proteomics. 14:2084–2088. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Haddad T and Kümmerer K: Characterization
of photo-transformation products of the antibiotic drug
Ciprofloxacin with liquid chromatography-tandem mass spectrometry
in combination with accurate mass determination using an LTQ
Orbitrap. Chemosphere. 115:40–46. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang JY, Wang F, Zhang H, Lu JQ and Qiao
YJ: Rapid identification of polymethoxylated flavonoids in
traditional Chinese medicines with a practical strategy of stepwise
mass defect filtering coupled to diagnostic product ions analysis
based on a hybrid LTQ Orbitrap mass spectrometer. Phytochem Anal.
25:405–414. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barrett JC, Fry B, Maller J and Daly MJ:
Haploview: Analysis and visualization of LD and haplotype maps.
Bioinformatics. 21:263–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi YY and He L: SHEsis, a powerful
software platform for analyses of linkage disequilibrium, haplotype
construction and genetic association at polymorphism loci. Cell
Res. 15:97–98. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Niu T: Algorithms for inferring
haplotypes. Genet Epidemiol. 27:334–347. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alexander DB, Iigo M, Yamauchi K, Suzui M
and Tsuda H: Lactoferrin: An alternative view of its role in human
biological fluids. Biochem Cell Biol. 90:279–306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nadolska B, Frączek M, Krȩcicki T, Koȩieba
M and Zimecki M: Lactoferrin inhibits the growth of nasal polyp
fibroblasts. Pharmacol Rep. 62:1139–1147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Manzoni P, Mostert M and Stronati M:
Lactoferrin for prevention of neonatal infections. Curr Opin Infect
Dis. 24:177–182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gibbons JA, Kanwar RK and Kanwar JR:
Lactoferrin and cancer in different cancer models. Front Biosci
(Schol Ed). 3:1080–10888. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang J, Li Q, Ou Y, Han Z, Li K, Wang P
and Zhou S: Inhibition of tumor growth by recombinant adenovirus
containing human lactoferrin through inducing tumor cell apoptosis
in mice bearing EMT6 breast cancer. Arch Pharm Res. 34:987–995.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yen CC, Shen CJ, Hsu WH, Chang YH, Lin HT,
Chen HL and Chen CM: Lactoferrin: An iron-binding antimicrobial
protein against Escherichia coli infection. Biometals. 24:585–594.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang C, Wu M, Tang Y, Li X, Ouyang J,
Xiao L, Li D and Li G: NAG7 promotes human nasopharyngeal carcinoma
invasion through inhibition of estrogen receptor alpha and
up-regulation of JNK2/AP-1/MMP1 pathways. J Cell Physiol.
221:394–401. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Raciti M, Lotti LV, Valia S, Pulcinelli FM
and Di Renzo L: JNK2 is activated during ER stress and promotes
cell survival. Cell Death Dis. 3:e4292012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cellurale C, Girnius N, Jiang F,
Cavanagh-Kyros J, Lu S, Garlick DS, Mercurio AM and Davis RJ: Role
of JNK in mammary gland development and breast cancer. Cancer Res.
72:472–481. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Radovich M, Hancock BA, Kassem N, Mi D,
Skaar TC and Schneider BP: Resequencing of the vascular endothelial
growth factor promoter reveals haplotype structure and functional
diversity. Angiogenesis. 13:211–218. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bruce JP and Liu FF: MicroRNAs in
nasopharyngeal carcinoma. Chin J Cancer. 33:539–544. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li HP, Huang HY, Lai YR, Huang JX, Chang
KP, Hsueh C and Chang YS: Silencing of miRNA-148a by
hypermethylation activates the integrin-mediated signaling pathway
in nasopharyngeal carcinoma. Oncotarget. 5:7610–7624. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma L, Deng X, Wu M, Zhang G and Huang J:
Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and
facilitates invasion of EBV-associated nasopharyngeal carcinoma
cells. FEBS Lett. 588:1562–1570. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Werk AN, Bruckmueller H, Haenisch S and
Cascorbi I: Genetic variants may play an important role in
mRNA-miRNA interaction: Evidence for haplotype-dependent
downregulation of ABCC2 (MRP2) by miRNA-379. Pharmacogenet
Genomics. 24:283–291. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Koelsch KA, Webb R, Jeffries M, Dozmorov
MG, Frank MB, Guthridge JM, James JA, Wren JD and Sawalha AH:
Functional characterization of the MECP2/IRAK1 lupus risk haplotype
in human T cells and a human MECP2 transgenic mouse. J Autoimmun.
41:168–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Kong D, Ahmad A, Bao B, Dyson G and
Sarkar FH: Epigenetic deregulation of miR-29a and miR-1256 by
isoflavone contributes to the inhibition of prostate cancer cell
growth and invasion. Epigenetics. 7:940–949. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bao L, Hazari S, Mehra S, Kaushal D, Moroz
K and Dash S: Increased expression of P-glycoprotein and
doxorubicin chemoresistance of metastatic breast cancer is
regulated by miR-298. Am J Pathol. 180:2490–2503. 2012. View Article : Google Scholar : PubMed/NCBI
|
